Strides Pharma Science Limited (NSE: STAR)

Strides Pharma Science Statistics

Total Valuation

Strides Pharma Science has a market cap or net worth of INR 140.60 billion. The enterprise value is 160.65 billion.

Market Cap	140.60B
Enterprise Value	160.65B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Sep 9, 2024

Share Statistics

Strides Pharma Science has 91.96 million shares outstanding. The number of shares has increased by 1.75% in one year.

Current Share Class	n/a
Shares Outstanding	91.96M
Shares Change (YoY)	+1.75%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	7.77%
Owned by Institutions (%)	31.12%
Float	57.05M

Valuation Ratios

The trailing PE ratio is 79.35 and the forward PE ratio is 28.79.

PE Ratio	79.35
Forward PE	28.79
PS Ratio	3.18
PB Ratio	6.19
P/TBV Ratio	12.33
P/FCF Ratio	22.16
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.86, with an EV/FCF ratio of 25.32.

EV / Earnings	69.46
EV / Sales	3.64
EV / EBITDA	21.86
EV / EBIT	29.57
EV / FCF	25.32

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.04.

Current Ratio	1.04
Quick Ratio	0.50
Debt / Equity	1.04
Debt / EBITDA	2.68
Debt / FCF	3.64
Interest Coverage	2.38

Financial Efficiency

Return on equity (ROE) is 8.19% and return on invested capital (ROIC) is 8.97%.

Return on Equity (ROE)	8.19%
Return on Assets (ROA)	6.78%
Return on Capital (ROIC)	8.97%
Revenue Per Employee	14.39M
Profits Per Employee	754,571
Employee Count	3,065
Asset Turnover	0.72
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +185.75% in the last 52 weeks. The beta is 0.80, so Strides Pharma Science's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+185.75%
50-Day Moving Average	1,479.10
200-Day Moving Average	1,082.15
Relative Strength Index (RSI)	54.90
Average Volume (20 Days)	266,720

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Strides Pharma Science had revenue of INR 44.10 billion and earned 2.31 billion in profits. Earnings per share was 25.17.

Revenue	44.10B
Gross Profit	24.85B
Operating Income	6.68B
Pretax Income	2.40B
Net Income	2.31B
EBITDA	8.24B
EBIT	6.68B
Earnings Per Share (EPS)	25.17

Balance Sheet

The company has 2.47 billion in cash and 23.08 billion in debt, giving a net cash position of -20.62 billion or -224.18 per share.

Cash & Cash Equivalents	2.47B
Total Debt	23.08B
Net Cash	-20.62B
Net Cash Per Share	-224.18
Equity (Book Value)	22.15B
Book Value Per Share	247.04
Working Capital	1.30B

Cash Flow

In the last 12 months, operating cash flow was 8.17 billion and capital expenditures -1.83 billion, giving a free cash flow of 6.34 billion.

Operating Cash Flow	8.17B
Capital Expenditures	-1.83B
Free Cash Flow	6.34B
FCF Per Share	68.99

Margins

Gross margin is 56.35%, with operating and profit margins of 15.15% and 5.24%.

Gross Margin	56.35%
Operating Margin	15.15%
Pretax Margin	5.43%
Profit Margin	5.24%
EBITDA Margin	18.68%
EBIT Margin	15.15%
FCF Margin	14.39%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.18%.

Dividend Per Share	2.50
Dividend Yield	0.18%
Dividend Growth (YoY)	66.67%
Years of Dividend Growth	n/a
Payout Ratio	10.46%
Buyback Yield	-1.75%
Shareholder Yield	-1.58%
Earnings Yield	1.65%
FCF Yield	4.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a